APA (7th ed.) Citation

Bin Lu, Longfei Shen, Ying Ma, Jia Qi, Jia Qi, Yulin Li, . . . Ming Zhong. (2022). Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin's lymphoma: A systematic review and meta-analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Bin Lu, Longfei Shen, Ying Ma, Jia Qi, Jia Qi, Yulin Li, Zhihao Wang, Lu Han, and Ming Zhong. Cardiovascular Adverse Events Associated with Cyclophosphamide, Pegylated Liposomal Doxorubicin, Vincristine, and Prednisone with or Without Rituximab ((R)-CDOP) in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Bin Lu, et al. Cardiovascular Adverse Events Associated with Cyclophosphamide, Pegylated Liposomal Doxorubicin, Vincristine, and Prednisone with or Without Rituximab ((R)-CDOP) in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis. Frontiers Media S.A., 2022.